
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
Kadimastem (TASE:KDST) A clinical stage biotech company introducing a cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells, providing OFF-THE-SHELF TREATMENT for multiple indications featuring ALS and Type 1 Diabetes as our top two leading projects
Stem cells,drug screening for myelin sheath,human oligodendrocytes,human beta cells,bio-banking,cell therapy,gmp facilities,cell production,type 1 diabetes,als,alstreatment,diabetescure,and clinicaltrials
Kadimastem ltd operates in the Biotechnology research industry.
Kadimastem ltd's revenue is 11m - 100m
Kadimastem ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.